{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T05:29:16Z","timestamp":1732166956217,"version":"3.28.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,20]]},"DOI":"10.7759\/cureus.74079","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T13:20:21Z","timestamp":1732108821000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Tophaceous Gout With Psoriatic Arthritis: A Case Report"],"prefix":"10.7759","author":[{"given":"Rui","family":"Coelho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel Fonseca","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Xavier Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.51866\/rv1165","article-title":"Management of gout in the primary care setting","volume":"17","author":"Low QJ","year":"2022","unstructured":"Low QJ, Lim TH, Hon SA, Low QJ, Wei MW, Cheo SW, Ramlan AH. Management of gout in the primary care setting. Malays Fam Physician. 2022, 17:2-9. 10.51866\/rv1165","journal-title":"Malays Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette P","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, et al.. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017, 76:29-42. 10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"key":"ref3","article-title":"EULAR Textbook on Rheumatic Diseases","author":"Bijlsma JWJ","year":"2018","unstructured":"Bijlsma JWJ, Hachulla E, da Silva JAP, et al.. EULAR Textbook on Rheumatic Diseases. BMJ Publishing Group, 2018."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/030006052110161","article-title":"Rheumatologists\u2019 understanding of refractory gout: a questionnaire survey in China","volume":"49","author":"Han X","year":"2021","unstructured":"Han X, Yin Y, Cao Y, et al.. Rheumatologists\u2019 understanding of refractory gout: a questionnaire survey in China. J Int Med Res. 2021, 49:03000605211016149. 10.1177\/030006052110161","journal-title":"J Int Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2020.1746804","article-title":"Refractory gout - does it exist?","volume":"39","author":"L\u00f6ffler W","year":"2020","unstructured":"L\u00f6ffler W, Fairbanks L. Refractory gout - does it exist?. Nuc Acids Res. 2020, 39:1410-23. 10.1080\/15257770.2020.1746804","journal-title":"Nuc Acids Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key402","article-title":"Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial","volume":"58","author":"Janssen CA","year":"2019","unstructured":"Janssen CA, Oude Voshaar MA, Vonkeman HE, et al.. Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial. Rheumatology (Oxford). 2019, 58:1344-1352. 10.1093\/rheumatology\/key402","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.41699","article-title":"A randomized, phase II study evaluating the efficacy and safety of anakinra in the treatment of gout flares","volume":"73","author":"Saag KG","year":"2021","unstructured":"Saag KG, Khanna PP, Keenan RT, et al.. A randomized, phase II study evaluating the efficacy and safety of anakinra in the treatment of gout flares. Arthritis Rheumatol. 2021, 73:1533-42. 10.1002\/art.41699","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132845","article-title":"Axial psoriatic disease: clinical and imaging assessment of an underdiagnosed condition","volume":"10","author":"Giovannini I","year":"2021","unstructured":"Giovannini I, Zabotti A, Cicci\u00f2 C, Salgarello M, Cereser L, De Vita S, Tinazzi I. Axial psoriatic disease: clinical and imaging assessment of an underdiagnosed condition. J Clin Med. 2021, 10:2845. 10.3390\/jcm10132845","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04981-0","article-title":"At the crossroads of gout and psoriatic arthritis: \"psout\"","volume":"39","author":"Felten R","year":"2020","unstructured":"Felten R, Duret PM, Gottenberg JE, Spielmann L, Messer L. At the crossroads of gout and psoriatic arthritis: \"psout\". Clin Rheumatol. 2020, 39:1405-13. 10.1007\/s10067-020-04981-0","journal-title":"Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/ar1589","article-title":"Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study","volume":"7","author":"Gibbs A","year":"2005","unstructured":"Gibbs A, Markham T, Walsh C, Bresnihan B, Veale D, FitzGerald O. Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study. Arthritis Res Ther. 2005, 7:P68. 10.1186\/ar1589","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1504-5","article-title":"An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)","volume":"29","author":"Jung N","year":"2010","unstructured":"Jung N, Hellmann M, Hoheisel R, et al.. An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clin Rheumatol. 2010, 29:1169-73. 10.1007\/s10067-010-1504-5","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03098-4","article-title":"Interleukin-1\u03b2 inhibitors for the management of acute gout flares: a systematic literature review","volume":"25","author":"Schlesinger N","year":"2023","unstructured":"Schlesinger N, Pillinger MH, Simon LS, Lipsky PE. Interleukin-1\u03b2 inhibitors for the management of acute gout flares: a systematic literature review. Arthritis Res Ther. 2023, 25:128. 10.1186\/s13075-023-03098-4","journal-title":"Arthritis Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000284","article-title":"Combination therapies of diacerein and febuxostat inhibit IL-1\u03b2 responses and improve clinical symptoms in patients with refractory gout","volume":"24","author":"Yu YK","year":"2017","unstructured":"Yu YK, Yu F, Ye C, Shen GF, Lei XM, Zhang ST, Hu SX. Combination therapies of diacerein and febuxostat inhibit IL-1\u03b2 responses and improve clinical symptoms in patients with refractory gout. Am J Ther. 2017, 24:e290-7. 10.1097\/MJT.0000000000000284","journal-title":"Am J Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316431-refractory-tophaceous-gout-with-psoriatic-arthritis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T13:20:23Z","timestamp":1732108823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316431-refractory-tophaceous-gout-with-psoriatic-arthritis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.74079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}